Search

18 January 2016 Paper Published: First-in-human trial of a live-attenuated Mycobacterium tuberculosis vaccine

18 Jan 2016 - 13:45

Associate Professor Mark Hatherill, SATVI Director, has co-authored a paper titled: "First-in-human trial of a live-attenuated Mycobacterium tuberculosis vaccine" appearing in the December issue of the Lancet Respiratory Medicine.

Click here to view abstract.